Business Context and Reporting Period
Company: SS Innovations International, Inc. (SSII)
Filing Type: Form 8-K (Current Report)
Date of Report: December 8, 2025
Reporting Period: Event-based report regarding regulatory submissions and operational updates as of December 5, 2025.
Key Financial Metrics
This filing is a Current Report on Form 8-K and does not contain audited financial statements, revenue figures, profit data, cash flow, margins, debt levels, or liquidity metrics. The filing text does not provide a clear value for any financial performance indicators.
Material Changes and Operational Updates
- FDA Submission: On December 5, 2025, the Company submitted a 510(k) premarket notification to the U.S. Food and Drug Administration (FDA) for its SSi Mantra surgical robotic system.
- Target Procedures: The submission covers multiple specialty procedure types, including general, urological, colorectal, gynecological, and cardiac surgery.
- Regulatory Progress: The Company provided updates regarding its European Union CE marking certification process.
- Installed Base: The Company provided updates on the cumulative installed base of SSi Mantra systems, though specific numbers were not detailed in the filing text.
Guidance, Outlook, and Risks
Management Commentary: The filing highlights the Company's progression in regulatory approvals for its flagship surgical robotic system in both the U.S. and EU markets.
Risks and Contingencies: The filing does not explicitly detail new risks or contingencies beyond the inherent uncertainties of regulatory approval processes (FDA 510(k) and EU CE marking). Success is contingent upon the FDA and EU authorities approving the submitted notifications.
Investor Verification Checklist
- Verify the status of the 510(k) premarket notification submitted to the FDA on December 5, 2025.
- Confirm the specific details of the cumulative installed base of SSi Mantra systems referenced in the press release (Exhibit 99.1).
- Monitor the timeline and requirements for the European Union CE marking certification process.
- Review the full text of the press release (Exhibit 99.1) for specific metrics on the installed base and regulatory milestones not included in the 8-K summary.